MYALEPTA
Google image searchProduct monograph
Active ingredient
metreleptin, 11.3 MG/VIAL
DIN: 02544571
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: CHIESI FARMACEUTICI S.P.A.
Date: 02-AUG-2024
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AA — Amino acids and derivatives (ATC, ATC/DDD)
- A16AA07 — METRELEPTIN (ATC/DDD)
